Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Guardant Health, Inc.GH · Entity 3238 | Chief Technology Officer | October 01, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Guardant Health, Inc.
Report date October 01, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 74,348 |
Ending reported balance
After 2026-10-01 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-10-01 · Exercise / conversion · Acquired 1,340 · Balance 71,975 Row 2 · 2026-10-01 · Exercise / conversion · Acquired 1,668 · Balance 73,643 Row 3 · 2026-10-01 · Exercise / conversion · Acquired 3,324 · Balance 76,967 Row 4 · 2026-10-01 · Exercise / conversion · Acquired 1,701 · Balance 78,668 Row 5 · 2026-10-01 · Tax withholding · Disposed 4,320 · Balance 74,348 F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-10-01 · Exercise / conversion · Disposed 1,340 · Balance 0 F2: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2026-10-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-10-01 · Exercise / conversion · Disposed 1,668 · Balance 0 F4: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 13,296 |
Reported balance
After 2026-10-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-10-01 · Exercise / conversion · Disposed 3,324 · Balance 13,296 F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 10,202 |
Reported balance
After 2026-10-01 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-10-01 · Exercise / conversion · Disposed 1,701 · Balance 10,202 F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3: Not applicable for Restricted Stock Units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter.
F3: Not applicable for Restricted Stock Units.
F4: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter.
F5: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
F6: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 3, 2026 00:59 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,701 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000018 · wk-form4_1790974793.xml · derivative · entry 9 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,202 Underlying: Common Stock · 1,701 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 00:59 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 3,324 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000018 · wk-form4_1790974793.xml · derivative · entry 8 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,296 Underlying: Common Stock · 3,324 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 00:59 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,668 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000018 · wk-form4_1790974793.xml · derivative · entry 7 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,668 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vested over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vested in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 00:59 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,340 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000018 · wk-form4_1790974793.xml · derivative · entry 6 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,340 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vested over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vested in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 00:59 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 4,320 | $174.75 | $754,920.00 |
DisclosureSEC source: 0001977179-26-000018 · wk-form4_1790974793.xml · nonDerivative · entry 5 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,348 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 00:59 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000018 · wk-form4_1790974793.xml · nonDerivative · entry 4 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,668 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 00:59 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 3,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000018 · wk-form4_1790974793.xml · nonDerivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,967 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 00:59 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,668 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000018 · wk-form4_1790974793.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2026 Filed Oct 3, 2026 00:59 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000018 · wk-form4_1790974793.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 21:11 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 7,738 | $178.00 | $1,377,364.00 |
DisclosureSEC source: 0001977179-26-000016 · wk-form4_1789679478.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,635 Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 22:10 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,700 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000014 · wk-form4_1783030248.xml · derivative · entry 9 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,903 Underlying: Common Stock · 1,700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 22:10 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 3,324 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000014 · wk-form4_1783030248.xml · derivative · entry 8 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,620 Underlying: Common Stock · 3,324 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 22:10 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000014 · wk-form4_1783030248.xml · derivative · entry 7 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,668 Underlying: Common Stock · 1,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 22:10 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,339 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000014 · wk-form4_1783030248.xml · derivative · entry 6 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,340 Underlying: Common Stock · 1,339 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 22:10 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 4,318 | $170.77 | $737,384.86 |
DisclosureSEC source: 0001977179-26-000014 · wk-form4_1783030248.xml · nonDerivative · entry 5 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,373 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 22:10 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000014 · wk-form4_1783030248.xml · nonDerivative · entry 4 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 22:10 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 3,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000014 · wk-form4_1783030248.xml · nonDerivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 22:10 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000014 · wk-form4_1783030248.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 22:10 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000014 · wk-form4_1783030248.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2026 Filed May 19, 2026 22:01 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 8,705 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000012 · wk-form4_1779228076.xml · derivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,706 Underlying: Common Stock · 8,705 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on August 7, 2023 and vests over a four-year period. 25% of the shares subject to such award vested on May 15, 2024 and the remaining 75% vests annually during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| May 15, 2026 Filed May 19, 2026 22:01 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 4,679 | $94.92 | $444,130.68 |
DisclosureSEC source: 0001977179-26-000012 · wk-form4_1779228076.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,402 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| May 15, 2026 Filed May 19, 2026 22:01 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 8,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000012 · wk-form4_1779228076.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,081 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 21:21 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 6,699 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000010 · wk-form4_1775164864.xml · derivative · entry 9 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,603 Underlying: Common Stock · 6,699 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This represents a restricted stock unit award granted on March 12, 2025 that vests over a three-year period. 33% of the shares subject to such award vested on April 1, 2026 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 21:21 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 3,324 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000010 · wk-form4_1775164864.xml · derivative · entry 8 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,944 Underlying: Common Stock · 3,324 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 21:21 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000010 · wk-form4_1775164864.xml · derivative · entry 7 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,335 Underlying: Common Stock · 1,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 21:21 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,339 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000010 · wk-form4_1775164864.xml · derivative · entry 6 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,679 Underlying: Common Stock · 1,339 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 21:21 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 7,005 | $91.15 | $638,505.75 |
DisclosureSEC source: 0001977179-26-000010 · wk-form4_1775164864.xml · nonDerivative · entry 5 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,376 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 21:21 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 6,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000010 · wk-form4_1775164864.xml · nonDerivative · entry 4 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 21:21 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 3,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000010 · wk-form4_1775164864.xml · nonDerivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 21:21 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000010 · wk-form4_1775164864.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 21:21 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000010 · wk-form4_1775164864.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,691 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 22:46 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionPerformance-Based Restricted Stock Units · Derivative | 10,714 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000008 · wk-form4_1773787594.xml · derivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,714 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on June 7, 2023 with a 3-year performance metric. The second tranche metric was achieved and the shares vested on March 15, 2026. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 22:46 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 5,759 | $85.49 | $492,336.91 |
DisclosureSEC source: 0001977179-26-000008 · wk-form4_1773787594.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,352 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 22:46 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 10,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000008 · wk-form4_1773787594.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,111 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 11, 2026 Filed Mar 14, 2026 00:33 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantRestricted Stock Units · Derivative | 23,856 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000006 · wk-form4_1773448385.xml · derivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,856 Underlying: Common Stock · 23,856 shares Expires not disclosed F1 · derivative.exercise_date: This represents a restricted stock unit award granted on March 11, 2026 that vests over a three-year period. 33% of the shares subject to such award will vest on April 1, 2027 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F2 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 22:57 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 3,324 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000002 · wk-form4_1767653867.xml · derivative · entry 12 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,268 Underlying: Common Stock · 3,324 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This represents a restricted stock unit award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 22:57 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionPerformance-Based Restricted Stock Units · Derivative | 5,688 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000002 · wk-form4_1767653867.xml · derivative · entry 11 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,688 Underlying: Common Stock · 5,688 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on February 26, 2024, that a performance metric was achieved and that 33% of the shares subject to such award vested on March 1, 2025. 33% of the shares subject to the award vested on January 1, 2026, and the remaining 34% of the shares subject to the award will vest on January 1, 2027. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 22:57 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000002 · wk-form4_1767653867.xml · derivative · entry 10 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,002 Underlying: Common Stock · 1,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This represents a restricted stock unit award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 22:57 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionPerformance-Based Restricted Stock Units · Derivative | 10,714 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000002 · wk-form4_1767653867.xml · derivative · entry 9 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,714 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This represents a performance-based restricted stock unit award granted on June 7, 2023, with a performance metric and 2-year vest period that was achieved. The shares vested on January 1, 2026. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 22:57 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionRestricted Stock Units · Derivative | 1,339 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000002 · wk-form4_1767653867.xml · derivative · entry 7 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,018 Underlying: Common Stock · 1,339 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on October 1, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 22:57 UTC | Guardant Health, Inc. GH · Entity 3238 | Tax withholdingCommon Stock | 12,316 | $102.14 | $1,257,956.24 |
DisclosureSEC source: 0001977179-26-000002 · wk-form4_1767653867.xml · nonDerivative · entry 6 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,428 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 22:57 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 3,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000002 · wk-form4_1767653867.xml · nonDerivative · entry 5 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 22:57 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 5,688 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000002 · wk-form4_1767653867.xml · nonDerivative · entry 4 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,420 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 22:57 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000002 · wk-form4_1767653867.xml · nonDerivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 22:57 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 10,714 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000002 · wk-form4_1767653867.xml · nonDerivative · entry 2 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 22:57 UTC | Guardant Health, Inc. GH · Entity 3238 | Exercise / conversionCommon Stock | 1,339 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000002 · wk-form4_1767653867.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,351 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 17, 2025 Filed Jan 22, 2026 22:42 UTC | Guardant Health, Inc. GH · Entity 3238 | GiftCommon Stock | 2,973 | $0.00 | $0.00 |
DisclosureSEC source: 0001977179-26-000004 · wk-form5_1769121738.xml · nonDerivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,397 F2 · shares: The gift of shares has been transferred to a charitable account over which Ms. Chudova has no voting power or control. Read SEC document |
| December 15, 2025 Filed Dec 18, 2025 00:17 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 5,451 | $104.04 | $567,131.85 |
DisclosureSEC source: 0001977179-25-000010 · wk-form4_1766017060.xml · nonDerivative · entry 1 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,012 F1 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $104.0401 to $104.0900. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 02:31 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 13,664 | $105.04 | $1,435,226.93 |
DisclosureSEC source: 0001977179-25-000008 · wk-form4_1765420294.xml · nonDerivative · entry 4 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Indirect · Chudova Family Trust Disclosed balance after: 54,480 F3 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.00 to $105.24. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 02:31 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCommon Stock | 9,271 | $106.00 | $982,752.89 |
DisclosureSEC source: 0001977179-25-000008 · wk-form4_1765420294.xml · nonDerivative · entry 3 Chudova Darya · CIK 0001977179 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,463 F2 · price: Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.11. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.